Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans

Nature Clinical Practice. Cardiovascular Medicine
Christoph A NienaberHüseyin Ince

Abstract

Recent experimental studies have shown that granulocyte-colony-stimulating factor (G-CSF) enhanced cardiac function after infarction. The concept of direct cytokine or cell-mediated effects on postischemic myocardial function was tested in the setting of human myocardial infarction subjected to percutaneous coronary intervention. In the FIRSTLINE-AMI study 50 consecutive patients with first ST-elevation myocardial infarction were randomly assigned to receive either 10 microg/kg G-CSF for 6 days after percutaneous coronary intervention in addition to standard medication, or standard care alone. G-CSF administration led to mobilization of CD34(+) mononuclear stem cells (MNC(CD34+)), with a 20-fold increase to 64 +/- 37 MNC(CD34+)/microl at day 6 without significant associated changes in rheology, blood viscosity or inflammatory reaction, or any major adverse effects. At 4 months the G-CSF group showed improved left ventricular ejection fraction of 54 +/- 8% versus 48 +/- 4% at baseline (P <0.001), and no evidence of left ventricular end-diastolic remodeling, with a diameter of 55 +/- 5 mm and improved segmental wall thickening (P <0.001); conversely, in control patients left ventricular ejection fraction was 43 +/- 5% at 4 months...Continue Reading

References

Mar 13, 1999·The Journal of Clinical Investigation·S MakinoS Ogawa
Apr 5, 2001·Nature·D OrlicP Anversa
Aug 16, 2001·Proceedings of the National Academy of Sciences of the United States of America·D OrlicP Anversa
Dec 18, 2001·Cardiovascular Research·Nikolaos G FrangogiannisMark L Entman
Jan 5, 2002·The New England Journal of Medicine·Federico QuainiPiero Anversa
Jan 24, 2002·Nature·Piero Anversa, Bernardo Nadal-Ginard
Apr 6, 2002·Circulation Research·Michael A LaflammeCharles E Murry
Jul 3, 2002·Circulation·Ruchira GlaserJonathan A Epstein
Jul 25, 2003·American Journal of Hematology·Dennis P O'MalleyPeter M Banks
Mar 9, 2005·Circulation·Jane A Leopold, Elliott M Antman

❮ Previous
Next ❯

Citations

Aug 27, 2009·Biologics : Targets & Therapy·Ana VillegasSantiago Redondo
Jul 29, 2009·Journal of Endocrinological Investigation·A ZeoliM F Brizzi
Sep 25, 2007·Trends in Pharmacological Sciences·Hiroyuki TakanoIssei Komuro
Sep 16, 2008·Trends in Cardiovascular Medicine·Sébastien TropAnnie Bourdeau
Jan 16, 2007·Journal of Molecular and Cellular Cardiology·Yasuyo IedaKeiichi Fukuda
Jan 16, 2009·Therapeutic Advances in Cardiovascular Disease·Kenichi Yamahara, Hiroshi Itoh
Nov 30, 2007·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Michael R WardMichael J B Kutryk
Apr 25, 2007·Annals of Medicine·Nikos Werner, Georg Nickenig
Dec 25, 2009·Expert Review of Molecular Diagnostics·Carlo ForestaAntonella Di Mambro
Nov 1, 2012·Current Opinion in Organ Transplantation·Anthony E Ting, Warren Sherman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.